L Ampollini

Summary

Affiliation: University of Parma
Country: Italy

Publications

  1. pmc Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
    Andrea Cavazzoni
    Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
    Mol Cancer 11:91. 2012
  2. doi Resection of giant typical carcinoid tumor with cardiopulmonary bypass support
    L Ampollini
    Department of Surgical Sciences, Thoracic Surgery, University Hospital of Parma, Parma, Italy
    Thorac Cardiovasc Surg 58:500-2. 2010
  3. doi Transcervical video-assisted thymectomy: preliminary results of a modified surgical approach
    Luca Ampollini
    Thoracic Surgery, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy
    Langenbecks Arch Surg 396:267-71. 2011
  4. ncbi Madelung's Disease
    Luca Ampollini
    University of Parma, Parma, Italy
    N Engl J Med 364:465. 2011
  5. ncbi A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery
    A Casati
    University of Parma, Department of Anaesthesiology and Pain Therapy, Ospedale Maggiore di Parma, Parma, Italy
    Eur J Anaesthesiol 23:999-1004. 2006

Collaborators

  • Paolo Del Rio
  • P Carbognani
  • A Casati
  • G Fanelli
  • Andrea Cavazzoni
  • Antonio Mutti
  • Elisabetta Barocelli
  • Claudia Fumarola
  • Paola Mozzoni
  • Marcello Tiseo
  • Elena Galvani
  • Daniele Cretella
  • Denise Madeddu
  • Silvia La Monica
  • Pier Giorgio Petronini
  • Roberta R Alfieri
  • Mara Bonelli
  • Maricla Galetti
  • Gallia Graiani
  • Andrea Ardizzoni
  • Francesca Saccani
  • Federico Quaini

Detail Information

Publications5

  1. pmc Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
    Andrea Cavazzoni
    Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
    Mol Cancer 11:91. 2012
    ..ErbB/HER-targeting by monoclonal antibodies such as cetuximab and trastuzumab or tyrosine-kinase inhibitors as gefitinib or erlotinib has been proven effective in the treatment of advanced NSCLC...
  2. doi Resection of giant typical carcinoid tumor with cardiopulmonary bypass support
    L Ampollini
    Department of Surgical Sciences, Thoracic Surgery, University Hospital of Parma, Parma, Italy
    Thorac Cardiovasc Surg 58:500-2. 2010
    ..We present the surgical strategy used to achieve a left pneumonectomy and the indications for cardiopulmonary bypass (CPB) support in a patient with a huge typical carcinoid tumor...
  3. doi Transcervical video-assisted thymectomy: preliminary results of a modified surgical approach
    Luca Ampollini
    Thoracic Surgery, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy
    Langenbecks Arch Surg 396:267-71. 2011
    ..A modified video-assisted transcervical approach to thymectomy is here described...
  4. ncbi Madelung's Disease
    Luca Ampollini
    University of Parma, Parma, Italy
    N Engl J Med 364:465. 2011
    ..08 mmol per liter]). Triglycerides were very elevated at 1020 mg per deciliter (11.52 mmol per liter). Magnetic resonance imaging revealed diffuse, nonencapsulated fatty deposits in the mediastinum and in the subcutaneous and . . ...
  5. ncbi A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery
    A Casati
    University of Parma, Department of Anaesthesiology and Pain Therapy, Ospedale Maggiore di Parma, Parma, Italy
    Eur J Anaesthesiol 23:999-1004. 2006
    ..The aim of this prospective, randomized, blinded study was to compare analgesic efficacy of continuous paravertebral and epidural analgesia for post-thoracotomy pain...